Results 141 to 150 of about 3,650 (207)

Injection Depot Medroxyprogesterone Acetate as an Early Postpartum Contraceptive Measure: Evaluation of Its Acceptability, Efficacy, and Impact on Lactation. [PDF]

Cureus
Srivastava Garg S, Bhateja B, Grover S, Tapasvi I.   +3 more
europepmc   +1 more source

An implementation project to expand access to self-administered depot medroxyprogesterone acetate (DMPA). [PDF]

Contraception, 2020
Katz M, Newmark RL, Aronstam A, O'Grady N, Strome S, Rafie S, Karlin J.   +6 more
europepmc   +1 more source

Bone density changes in young women in Uganda using tenofovir-based HIV preexposure prophylaxis and depot medroxyprogesterone acetate contraception. [PDF]

AIDS
Heffron R, Muwonge TR, Thomas KK, Zewdie K, Ssebuliba T, Stein G, Morrison S, Badaru J, Nakyanzi A, Bambia F, Mugwanya K, Wyatt C, Matovu F, Yin MT, Mujugira A.   +14 more
europepmc   +1 more source

Correction to: Incidence of Herpes Simplex Virus Type 2 Infection Among African Women Using Depot Medroxyprogesterone Acetate, a Copper Intrauterine Device, or a Levonorgestrel Implant for Contraception: A Nested Randomized Trial. [PDF]

Clin Infect Dis, 2023
europepmc   +1 more source

Depot Medroxyprogesterone Acetate Use and Blood Lead Levels in a Cohort of Young Women. [PDF]

Environ Health Perspect, 2020
Upson K, Harmon QE, Heffron R, Hall JE, Wise LA, Wegienka G, Tokar EJ, Baird DD.   +7 more
europepmc   +1 more source

The injectable contraceptives depot medroxyprogesterone acetate and norethisterone enanthate substantially and differentially decrease testosterone and sex hormone binding globulin levels: A secondary study from the WHICH randomized clinical trial. [PDF]

PLoS One
Avenant C, Singata-Madliki M, Bick AJ, Africander D, Balakrishna Y, Storbeck KH, Moliki JM, Dlamini S, Skosana S, Smit J, Beksinska M, Beesham I, Seocharan I, Batting J, Hofmeyr GJ, Hapgood JP.   +15 more
europepmc   +1 more source

Understanding the Acceptability of Depot Medroxyprogesterone Acetate (ANTARA) among Women of Reproductive Age from the Lens of Grassroot Level Providers in Rural and Urban Areas of Nagpur, India.

Ann Afr Med
Lakshmi NRA, Dani A, Vithalani NJ, Ramasamy N, Dongre AR, Vijayageetha M.   +5 more
europepmc   +1 more source

Sexual behaviour among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: Data from the ECHO randomized trial. [PDF]

PLoS One
Hofmeyr GJ, Singata-Madliki M, Batting J, Steyn P, Thomas KK, Issema R, Beesham I, Mbatsane E, Morrison C, Deese J, Smit J, Philip N, Palanee-Phillips T, Reddy K, Onono M, Mastro TD, Baeten JM, Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial Consortium.   +17 more
europepmc   +1 more source

Effects of depot medroxyprogesterone acetate, the copper IUD and the levonorgestrel implant on testosterone, sex hormone binding globulin and free testosterone levels: ancillary study of the ECHO randomized clinical trial. [PDF]

BMC Womens Health
Hofmeyr GJ, Singata-Madliki M, Batting J, Balakrishna Y, Morroni C.   +4 more
europepmc   +1 more source

Effects of injectable contraception with depot medroxyprogesterone acetate or norethisterone enanthate on estradiol levels and menstrual, psychological and behavioral measures relevant to HIV risk: The WHICH randomized trial. [PDF]

PLoS One
Singata-Madliki M, Smit J, Beksinska M, Balakrishna Y, Avenant C, Beesham I, Seocharan I, Batting J, Hapgood JP, Hofmeyr GJ.   +9 more
europepmc   +1 more source